What is the ROCE (Return on Capital Employed) of PharmAbcine this year?
The ROCE of PharmAbcine is -0.73 undefined this year.
PharmAbcine ROCE 2024
PharmAbcine ROCE
-0.73
Ticker
208340.KQ
ISIN
KR7208340000
In 2024, PharmAbcine's return on capital employed (ROCE) was -0.73, a -22.33% increase from the -0.94 ROCE in the previous year.
PharmAbcine Aktienanalyse
What does PharmAbcine do?
PharmAbcine ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling PharmAbcine's Return on Capital Employed (ROCE)
PharmAbcine's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing PharmAbcine's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
PharmAbcine's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in PharmAbcine’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about PharmAbcine stock
How has the ROCE (Return on Capital Employed) of PharmAbcine developed compared to the previous year?
The ROCE of PharmAbcine has increased by -22.33% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of PharmAbcine?
A high Return on Capital Employed (ROCE) indicates that PharmAbcine has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of PharmAbcine?
A low ROCE (Return on Capital Employed) can indicate that PharmAbcine has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from PharmAbcine impact the company?
An increase in the ROCE of PharmAbcine can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of PharmAbcine affect the company?
A decrease in ROCE of PharmAbcine can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of PharmAbcine?
Some factors that can affect PharmAbcine's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of PharmAbcine so important for investors?
The ROCE of PharmAbcine is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can PharmAbcine take to improve the ROCE?
To improve the ROCE, PharmAbcine can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does PharmAbcine pay?
Over the past 12 months, PharmAbcine paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PharmAbcine is expected to pay a dividend of 0 KRW.
What is the dividend yield of PharmAbcine?
The current dividend yield of PharmAbcine is .
When does PharmAbcine pay dividends?
PharmAbcine pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PharmAbcine?
PharmAbcine paid dividends every year for the past 0 years.
What is the dividend of PharmAbcine?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is PharmAbcine located?
PharmAbcine is assigned to the 'Health' sector.
Wann musste ich die Aktien von PharmAbcine kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PharmAbcine from 10/7/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 10/7/2024.
When did PharmAbcine pay the last dividend?
The last dividend was paid out on 10/7/2024.
What was the dividend of PharmAbcine in the year 2023?
In the year 2023, PharmAbcine distributed 0 KRW as dividends.
In which currency does PharmAbcine pay out the dividend?
The dividends of PharmAbcine are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PharmAbcine
Our stock analysis for PharmAbcine Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmAbcine Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.